1Munoz P,Fernandez-Turegano CP.Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole[J].Diagn Microbiol Infect Dis,2002,44(2):163-167.
2Vazquez JA.Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients[J].HIV Clin Trials,2000,1(1):47-59.
3CDC.Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults[J].MMWR,1992,41:17.
4Gaissert HA,Roper CL.Infectious necrotizing esophagitis:outcome after medical and surgical intervention[J].Ann Thorac Surg,2003,75(2):342-347.
5Calore EE,Cavaliere JM.Esophageal ulcers in AIDS[J].Pathologica,1997,89(2):155-158.
6Le Monte AM,Goldman M.DNA fingerprinting of serial candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS[J].Med Mycol,2001,39(2):207-213.
7Garber GE.Treatment of oral Candida mucositis infections[J].Drugs,1994,47(5):734-740.
8Vazquez JA.Options for the management of mucosal candidiasis in patients with AIDS and HIV infection[J].Pharmacotherapy,1999,19(1):76-87.
同被引文献2
1Vazquez JA.Options for the management of mucosal candidiar sis in patients with AIDS and HIV infection[J].Phannacother apy,1999,19(1):76.
